Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mearns

Showing results (471-480 of 484) with videos related to

Pageof 49
Sort By:
Environmental Health : a Global Access Science Source|January 28, 2010
Strategies for monitoring and managing mass populations of toxic cyanobacteria in recreational waters: a multi-interdisciplinary approachAndrew N Tyler, Peter D Hunter, Laurence Carvalho, et al.
Mucosal Immunology|August 26, 2010
IL-4Rα-responsive smooth muscle cells contribute to initiation of TH2 immunity and pulmonary pathology in Nippostrongylus brasiliensis infectionsW G C Horsnell, A Vira, F Kirstein, et al.
Gels (Basel, Switzerland)|March 28, 2023
Advanced Polymeric Membranes as Biomaterials Based on Marine Sources Envisaging the Regeneration of Human TissuesDuarte Nuno Carvalho, Flávia C M Lobo, Luísa C Rodrigues, et al.
Biochemistry|May 25, 2005
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondriaBoris F Krasnikov, Soo-Youl Kim, Stephen J McConoughey, et al.
Vaccine|November 22, 2016
H1:IC31 vaccination is safe and induces long-lived TNF-α<sup>+</sup>IL-2<sup>+</sup>CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.
Heart Rhythm|October 21, 2015
Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative interventionTomos E Walters, Ashley Nisbet, Gwilym M Morris, et al.
Vaccine|April 12, 2015
A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringeHennie D Geldenhuys, Helen Mearns, Jennifer Foster, et al.
Vaccine|June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trialHennie Geldenhuys, Helen Mearns, David J C Miles, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
BMJ Global Health|September 23, 2025
Progress in epidemic-ready primary health care: early pilot results from four African countries (Ethiopia, Nigeria, Sierra Leone and Uganda), December 2023 - October 2024Stacey Leanne Mearns, Moreen Kamateeka, Tochi Okwor, et al.
Pageof 49

Showing results (471-480 of 484) with videos related to

Sort By:
Pageof 49
Environmental Health : a Global Access Science Source|January 28, 2010
Strategies for monitoring and managing mass populations of toxic cyanobacteria in recreational waters: a multi-interdisciplinary approachAndrew N Tyler, Peter D Hunter, Laurence Carvalho, et al.
Mucosal Immunology|August 26, 2010
IL-4Rα-responsive smooth muscle cells contribute to initiation of TH2 immunity and pulmonary pathology in Nippostrongylus brasiliensis infectionsW G C Horsnell, A Vira, F Kirstein, et al.
Gels (Basel, Switzerland)|March 28, 2023
Advanced Polymeric Membranes as Biomaterials Based on Marine Sources Envisaging the Regeneration of Human TissuesDuarte Nuno Carvalho, Flávia C M Lobo, Luísa C Rodrigues, et al.
Biochemistry|May 25, 2005
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondriaBoris F Krasnikov, Soo-Youl Kim, Stephen J McConoughey, et al.
Vaccine|November 22, 2016
H1:IC31 vaccination is safe and induces long-lived TNF-α<sup>+</sup>IL-2<sup>+</sup>CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.
Heart Rhythm|October 21, 2015
Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative interventionTomos E Walters, Ashley Nisbet, Gwilym M Morris, et al.
Vaccine|April 12, 2015
A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringeHennie D Geldenhuys, Helen Mearns, Jennifer Foster, et al.
Vaccine|June 7, 2015
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trialHennie Geldenhuys, Helen Mearns, David J C Miles, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
BMJ Global Health|September 23, 2025
Progress in epidemic-ready primary health care: early pilot results from four African countries (Ethiopia, Nigeria, Sierra Leone and Uganda), December 2023 - October 2024Stacey Leanne Mearns, Moreen Kamateeka, Tochi Okwor, et al.
Pageof 49